These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7864528)

  • 21. Accelerator mass spectrometry for the detection of ultra-low levels of plutonium in urine, including that excreted after the ingestion of Irish sea sediments.
    Priest ND; Pich GM; Fifield LK; Cresswell RG
    Radiat Res; 1999 Dec; 152(6 Suppl):S16-8. PubMed ID: 10564928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of early Los Alamos internal exposures to plutonium.
    Miller G; Bertelli L; Guilmette R; McNaughton MW; Eisele WF
    Radiat Prot Dosimetry; 2008; 130(4):503-9. PubMed ID: 18375946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A computational study of the urinary excretion rates for 339Pu using new ICRP internal dosimetry models.
    Singh IS; Sharma RC; Abani MC
    Radiat Prot Dosimetry; 2003; 105(1-4):361-4. PubMed ID: 14526987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Monte Carlo method for calculating Bayesian uncertainties in internal dosimetry.
    Puncher M; Birchall A
    Radiat Prot Dosimetry; 2008; 132(1):1-12. PubMed ID: 18806256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative evaluation of inhalation exposure to plutonium -238 and plutonium-239 nitrates].
    Demina PA; Khalturin GV; Andriushkeeva NI; Kuz'menko OV; Nikitina LV
    Gig Sanit; 1991 Mar; (3):48-50. PubMed ID: 1885016
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapid screening methods for the analysis of Pu or Am in urine.
    Ide HM; Moss WD; Gautier MA
    Health Phys; 1985 Nov; 49(5):970-6. PubMed ID: 4066357
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determination of the plutonium-239 content of the body].
    Shvydko NS; Ivanova NP; Pushonik SI
    Radiobiologiia; 1988; 28(4):545-8. PubMed ID: 3420230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity analysis of the urinary excretion of plutonium.
    Luciani A; Doerfel H; Polig E
    Radiat Prot Dosimetry; 2001; 93(2):179-83. PubMed ID: 11548342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rapid and quantitative method for the detection of plutonium in urine.
    Valentin N; Weyers C; Luysterborg J
    Health Phys; 1966 Apr; 12(4):577-8. PubMed ID: 5960278
    [No Abstract]   [Full Text] [Related]  

  • 30. THE DISTRIBUTION OF 239PU IN THE BODY FOLLOWING EXPOSURE BY INHALATION.
    SNYDER WS
    Health Phys; 1964 Dec; 10():1035-42. PubMed ID: 14244749
    [No Abstract]   [Full Text] [Related]  

  • 31. Uncertainties analysis for the plutonium dosimetry model, doses-2005, using Mayak bioassay data.
    Bess JD; Krahenbuhl MP; Miller SC; Slaughter DM; Khokhryakov VV; Khokhryakov VF; Suslova KG; Vostrotin VV
    Health Phys; 2007 Sep; 93(3):207-19. PubMed ID: 17693771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
    Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
    Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of an alpha track analysis and a fission track analysis for determining the hot particles contaminated with Pu and U isotopes.
    Lee MH; Park YJ; Jee KY; Kim WH; Clark SB
    Appl Radiat Isot; 2007 Jan; 65(1):85-91. PubMed ID: 16934476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium.
    Gervelas C; Serandour AL; Geiger S; Grillon G; Fritsch P; Taulelle C; Le Gall B; Benech H; Deverre JR; Fattal E; Tsapis N
    J Control Release; 2007 Mar; 118(1):78-86. PubMed ID: 17241685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plutonium in the Ozyorsk population.
    Suslova KG; Khokhryakov VF; Sokolova AB
    Radiat Prot Dosimetry; 2007; 127(1-4):502-6. PubMed ID: 17545660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of plutonium exposure in the Enewetak population by urinalysis.
    Sun LC; Meinhold CB; Moorthy AR; Kaplan E; Baum JW
    Health Phys; 1997 Jul; 73(1):127-32. PubMed ID: 9199223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Method of determining the plutonium content of wounds].
    Dolgirev EI; Kaĭdanovskiĭ GN
    Med Radiol (Mosk); 1984 Sep; 29(9):26-30. PubMed ID: 6482702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of contributions of human tissue studies to biokinetics, bioeffects and dosimetry of plutonium in man.
    Kathren RL
    Radiat Prot Dosimetry; 2004; 109(4):399-407. PubMed ID: 15273358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of monitoring for internal exposure by urine bioassay in a biomedical research facility.
    Shoji M; Kondo T; Honoki H; Nakajima T; Muraguchi A; Saito M
    Radiat Prot Dosimetry; 2007; 127(1-4):456-60. PubMed ID: 17956934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicity of inhaled plutonium dioxide in beagle dogs.
    Muggenburg BA; Guilmette RA; Mewhinney JA; Gillett NA; Mauderly JL; Griffith WC; Diel JH; Scott BR; Hahn FF; Boecker BB
    Radiat Res; 1996 Mar; 145(3):361-81. PubMed ID: 8927705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.